Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariona Parera

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Methods in Cell Biology|January 25, 2025
Antimicrobial regime for gut microbiota depletion in experimental mice modelsLaura Carrillo-Serradell, Alessandra Borgognone, Marc Noguera-Julian, et al.
Immunobiology|July 24, 2012
HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32Ester Ballana, Eva Riveira-Munoz, Christian Pou, et al.
Vaccines|November 25, 2023
Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum LevelsAleix Elizalde-Torrent, Alessandra Borgognone, Maria Casadellà, et al.
Microbiome|May 13, 2019
Evolution of the gut microbiome following acute HIV-1 infectionMuntsa Rocafort, Marc Noguera-Julian, Javier Rivera, et al.
Nature Communications|April 27, 2026
Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trialFrancesc Català-Moll, Carlos Blázquez-Bondia, Judit Farré-Badia, et al.
Nature Communications|March 4, 2026
Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trialFrancesc Català-Moll, Carlos Blázquez-Bondia, Judit Farré-Badia, et al.
Viruses|December 28, 2021
First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in SpainLeira Fernández-Bastit, Jordi Rodon, Edwards Pradenas, et al.
Transboundary and Emerging Diseases|September 28, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and humoral responses against different variants of concern in domestic pet animals and stray cats from North-Eastern SpainLeira Fernández-Bastit, Silvia Marfil, Edwards Pradenas, et al.
The Lancet. Microbe|May 11, 2022
Yaws re-emergence and bacterial drug resistance selection after mass administration of azithromycin: a genomic epidemiology investigationMathew A Beale, Marc Noguera-Julian, Charmie Godornes, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2020
Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in SpainJoaquim Segalés, Mariona Puig, Jordi Rodon, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Methods in Cell Biology|January 25, 2025
Antimicrobial regime for gut microbiota depletion in experimental mice modelsLaura Carrillo-Serradell, Alessandra Borgognone, Marc Noguera-Julian, et al.
Immunobiology|July 24, 2012
HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32Ester Ballana, Eva Riveira-Munoz, Christian Pou, et al.
Vaccines|November 25, 2023
Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum LevelsAleix Elizalde-Torrent, Alessandra Borgognone, Maria Casadellà, et al.
Microbiome|May 13, 2019
Evolution of the gut microbiome following acute HIV-1 infectionMuntsa Rocafort, Marc Noguera-Julian, Javier Rivera, et al.
Nature Communications|April 27, 2026
Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trialFrancesc Català-Moll, Carlos Blázquez-Bondia, Judit Farré-Badia, et al.
Nature Communications|March 4, 2026
Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trialFrancesc Català-Moll, Carlos Blázquez-Bondia, Judit Farré-Badia, et al.
Viruses|December 28, 2021
First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in SpainLeira Fernández-Bastit, Jordi Rodon, Edwards Pradenas, et al.
Transboundary and Emerging Diseases|September 28, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and humoral responses against different variants of concern in domestic pet animals and stray cats from North-Eastern SpainLeira Fernández-Bastit, Silvia Marfil, Edwards Pradenas, et al.
The Lancet. Microbe|May 11, 2022
Yaws re-emergence and bacterial drug resistance selection after mass administration of azithromycin: a genomic epidemiology investigationMathew A Beale, Marc Noguera-Julian, Charmie Godornes, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2020
Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in SpainJoaquim Segalés, Mariona Puig, Jordi Rodon, et al.
Pageof 5